Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)

Cited by papers we hold 4

• Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends · 2023
  No notice
• Recent advances in non-small cell lung cancer targeted therapy; an update review · 2023
  No notice
• Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies · 2021
  No notice
• Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.